Publication
Toward Meeting the Obligation of Respect for Persons in Pragmatic Clinical Trials
Downloadable Content
- Persistent URL
- Last modified
- 09/24/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2022-05-01
- Publisher
- Wiley
- Publication Version
- Copyright Statement
- © 2022 The Hastings Center
- Final Published Version (URL)
- Title of Journal or Parent Work
- Volume
- 52
- Issue
- 3
- Start Page
- 9
- End Page
- 17
- Abstract
- Research ethics oversight systems have traditionally emphasized the informed consent process as the primary means by which to demonstrate respect for prospective subjects. Yet how researchers can best fulfill the ethical obligations of respect for persons in pragmatic clinical trials (PCTs)—particularly those that may alter or waive informed consent—remains unknown. We propose eight dimensions of demonstrating respect in PCTs: (1) engaging patients and communities in research design and execution, (2) promoting transparency and open communication, (3) maximizing agency, (4) minimizing burdens and promoting accessibility, (5) protecting privacy and confidentiality, (6) valuing interpersonal interactions with clinicians and study team members, (7) providing compensation, and (8) maximizing social value. While what respect requires in the context of PCTs will vary based on the nature of the PCT in question, the breadth of these dimensions demonstrates that respect obligations extend beyond informed consent processes.
- Author Notes
- Keywords
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - w6qc0.pdf | Primary Content | 2025-06-02 | Public | Download |